Wintrust Financial Corporation »

Arcturus Therapeutics Hldg I shares owned by Wintrust Financial Corporation

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Wintrust Financial Corporation from 13F filings

Historical chart of Wintrust Financial Corporation investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Wintrust Financial Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Wintrust Financial Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5M 207k 31.53

More positions owned by Wintrust Financial Corporation

Microsoft Corporation (MSFT)
J P Morgan Chase And CS (JPM)
Exxon Mobil Corp CS (XOM)
Unitedhealth Gp CS (UNH)
Boston Scientific Corp CS (BSX)
BlackRock (BLK)
Abbott Laboratories CS (ABT)
Bank of America Corporation (BAC)
Apple (AAPL)
Comcast Corp CS (CMCSA)
Conocophillips CS (COP)
Schlumberger CS (SLB)
Parker Hannifin Corp CS (PH)
Berkshire Hathaway Cl B CS (BRK.B)
WELLS FARGO and CS (WFC)

View all positions for Wintrust Financial Corporation

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
ARK Investment Management
Vanguard Group
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Dimensional Fund Advisors
Goldman Sachs Group
Schonfeld Strategic Advisors
Jupiter Asset Management
Jpmorgan Chase & Co
Wintrust Financial Corporation
Charles Schwab Investment Management
AQR Capital Management
Caption Management
Portolan Capital Management

View all funds holding Arcturus Therapeutics Hldg I